Article ID Journal Published Year Pages File Type
2579491 Thérapie 2008 9 Pages PDF
Abstract
The use of anti-TNFα drugs has progressed over the last 4 years, in accordance with the “contrat de bon usage”. This is due to a better knowledge of these drugs, a good evolution of guidelines and the active participation of the medical team in the “contrat de bon usage” plan.
Related Topics
Health Sciences Pharmacology, Toxicology and Pharmaceutical Science Pharmacology, Toxicology and Pharmaceutics (General)
Authors
, , , ,